Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Bayer Healthcare Pharmaceuticals Inc.

Bayer Healthcare Pharmaceuticals Inc. Recalls

All product recalls associated with Bayer Healthcare Pharmaceuticals Inc..

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

567

Class I (Serious)

Most Recent

Jan 2026

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 2461–2480 of 7756 recalls

LOTRIMIN AF Deodorant Powder Spray (Bayer) - Manufacturing Deviation (2021)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Class IIModerate

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

Lotrimin AF Daily Prevention Powder Spray (Bayer) - Benzene Contamination (2021)

Chemical Contamination: presence of benzene

Class IHigh

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

Tinactin Deodorant Powder Spray (Bayer) - Benzene Contamination (2021)

Chemical Contamination: presence of benzene

Class I

1...122 123124125 126...388

Page 124 of 388Next

High

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

Tinactin Powder Spray (Bayer) – Benzene Contamination (2021)

Chemical Contamination: presence of benzene

Class IHigh

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

Lotrimin AF Liquid Spray (Bayer) - Manufacturing Deviation (2021)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Class IIModerate

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

LOTRIMIN AF Daily Prevention Spray (Bayer) - Manufacturing Deviation (2021)

cGMP Deviations: LOTRIMIN AF (Tolnaftate 1%) manufactured at the same facility where other lots were found to be contaminated with benzene.

Class IIModerate

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

LOTRIMIN AF Jock Itch Powder Spray (Bayer) - Manufacturing Deviation (2021)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Class IIModerate

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

LOTRIMIN AF Jock Itch Powder Spray (Bayer) - Benzene Contamination (2021)

Chemical Contamination: presence of benzene

Class IHigh

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

LOTRIMIN AF Powder Spray (Bayer) - Benzene Contamination (2021)

Chemical Contamination: presence of benzene

Class IHigh

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

Tinactin Liquid Spray (Bayer) - Manufacturing Deviation (2021)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Class IIModerate

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

Tinactin Deodorant Powder (Bayer) – Manufacturing Deviation (2021)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Class IIModerate

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

Tinactin Jock Itch Powder Spray (Bayer) - Benzene Contamination (2021)

Chemical Contamination: presence of benzene

Class IHigh

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

LOTRIMIN AF Daily Prevention Spray (Bayer) - Manufacturing Deviation (2021)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Class IIModerate

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

LOTRIMIN AF Deodorant Powder Spray (Bayer) - Benzene Contamination (2021)

Chemical Contamination: presence of benzene

Class IHigh

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

LOTRIMIN AF Daily Prevention Spray (Bayer) - Manufacturing Deviation (2021)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Class IIModerate

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

LOTRIMIN AF Powder Spray (Bayer) - Manufacturing Deviation (2021)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Class IIModerate

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

Tinactin Powder Spray (Bayer) - Manufacturing Deviation (2021)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Class IIModerate

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

Tinactin Jock Itch Powder Spray (Bayer) - Manufacturing Deviation (2021)

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Class IIModerate

FDAOct 1, 2021Nationwide• Bayer Healthcare Pharmaceuticals Inc.

Baxter Healthcare Corporation: Hemodialysis Delivery System, Software Version 2.x.

If the operator initiates therapy with a saved prescription profile and makes a change to the prescription after a disposable filter change using the Same Patient button, the system may suggest values from the original prescription profile, rather than the current prescription.

FDASep 29, 2021Nationwide• Baxter Healthcare Corporation

Abbott Laboratories: ARCHITECT i1000SR REF 01L86-01/1L86 and 1L87; ARCHITECT i...

Twelve software-related issues affecting software version 9.41 and earlier were identified. The issues include bypassing error codes, incorrect calibration, loss of module communication leading to overfilling wash buffer containers, missing QC flags, signal spikes, abnormal optics reads, and incorrect sample aspiration. The issues may lead to inaccurate results with an unknown bias direction and magnitude for assays measuring cardiac, metabolic (including diabetes), toxicology, prenatal, therapeutic drug monitoring, infectious disease, oncology, hepatic, pancreatic, hematological, endocrinologic, inflammatory analytes.

FDASep 29, 2021AL, AK, AZ +47 more• Abbott Laboratories